Questions discussed in this category
In light of ANNEXA-I RCT results: Connolly et al., PMID 38749032.
Do you increase rivaroxaban to 10 mg daily during the inpatient stay, or do you prefer to add LMWH or SC heparin?
Assume thrombolytics are not indicated. Do you favor early DOAC transition after 24-48 hours of heparin gtt or do you favor LMWH for 10-14 days follow...
Are there specific mass features that would influence your treatment decision?
Is it different than early mobility that we always encourage?
Practice is variable in the community, with some hematologists frequently prescribing ESAs for severe anemia that is mostly inflammatory. Do the risks...
If hydroxyurea modifies the course of sickle cell disease by increasing fetal hemoglobin, is there any benefit to using it in patients with fetal hemo...
Please comment on temperature recommendations and role of exchange transfusion.
What is your preferred agent (DOAC, warfarin, enoxaparin), and is periprocedural bridging necessary?
e.g. DITP from eptifibatide after a cardiac intervention
How does cirrhosis and/or underlying thrombophilia affect your decision?
Does manipulation of blood products (leukoreduction, irradiated) affect your approach? There is growing evidence that routine premedication (at least ...
What are your target goals during transfusion, either prophylactically or during acute complication? Does your management change between vaginal deliv...
Especially in a triple-positive patient with an acute ischemic stroke who may have urgency for anticoagulation with high bleeding risk and severe thro...
How do you manage an uncomplicated DHTFR versus a hyperhemolysis?
Should we use a different dose in critically ill patients in the ICU? When should we consider intermediate-dose anticoagulation?
Would you offer this routinely or only if specific complications arise, such as distal emboli?
8566202001968922445138792053420571204671727518445182577520160071280115988153261428514674122591197510958104761042082299451895288798675802179417800
Papers discussed in this category
Blood, 2021 Apr 01
Blood, 2015-05-28
Blood Adv, 2020 Jan 28
Blood, 2015 Aug 24
Lancet, 2016 May 10
J Vasc Interv Radiol, 2020 Sep 09
Journal of thrombosis and haemostasis : JTH, 2018-06-07
Transfusion, 2017 May 03
J Clin Med, 2020 Nov 23
Am J Hematol, 2012 May 28
Blood Adv,
Hematology. American Society of Hematology. Education Program, 2015
British journal of haematology, 2015-10
Journal of hospital medicine, 2019-01
The New England journal of medicine, 2019 Feb 18
Phlebology, 2020 Mar 02
VASA. Zeitschrift fur Gefasskrankheiten, 2001 Jul
Journal of vascular surgery, 2000 Nov
Lancet Neurol, 2019 May 23
The Lancet. Neurology, 2021 Mar 17
The New England journal of medicine, 2024 May 16
The Lancet. Haematology, 2021 Aug 04
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2023 Jan-Dec
Blood advances, 2018-11-27